FIVVX
Price
$40.62
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VMVAX
Price
$88.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FIVVX vs VMVAX

Header iconFIVVX vs VMVAX Comparison
Open Charts FIVVX vs VMVAXBanner chart's image
Delaware Opportunity R6
Price$40.62
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$88.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FIVVX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIVVX vs. VMVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIVVX is a StrongBuy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. FIVVX (512M). VMVAX pays higher dividends than FIVVX: VMVAX (2.14) vs FIVVX (1.12). FIVVX was incepted earlier than VMVAX: FIVVX (12 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. FIVVX (11.00). FIVVX has a lower initial minimum investment than VMVAX: FIVVX (0) vs VMVAX (3000). FIVVX annual gain was more profitable for investors over the last year : 30.35 vs. VMVAX (28.30). VMVAX return over 5 years is better than : 48.86 vs. FIVVX (2.50).
FIVVXVMVAXFIVVX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD20.39118.476110%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets512M30.9B2%
Annual Yield % from dividends1.122.1452%
Returns for 1 year30.3528.30107%
Returns for 3 years6.8814.9846%
Returns for 5 years2.5048.865%
Returns for 10 years1.71100.722%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U19.13-0.09
-0.47%
Unity Software
MP19.12-0.73
-3.68%
MP Materials Corp
MLAB107.79-4.62
-4.11%
Mesa Laboratories
TTNP4.15-0.26
-6.00%
Titan Pharmaceuticals
LPTX2.99-0.25
-7.85%
Leap Therapeutics